Huller Kelly's Form 4 filing
Globus Medical Inc (GMED) · filed Feb 27, 2026
- Accession no.
- 0001193125-26-083348
- Filed
- Feb 27, 2026
- Trade date
- Feb 25, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.89M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Huller KellyCIK 0001768417 | Officer (EVP, GC, Corporate Secretary) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 25, 2026 | Class A Common Stock | MOption exerciseAcquired | +20,000 | $43.58 | +$871,600 | 20,000 | Direct | |
| Feb 25, 2026 | Class A Common Stock | SSaleDisposed | −20,000 | $94.50 | −$1,890,000 | 0 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 25, 2026 | Class A Common Stock | MOption exerciseDisposed | −20,000 | $0.00 | $0 | 20,000 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.